BLOOD CANCER ALLIANCE

Registered charity 1202693 · accounts filings on the Charity Commission register

The Blood Cancer Alliance aim to improve the lives of those living with blood cancer in the UK by raising the profile of the unique issues faced by patients and encouraging focused healthcare policy.

Objects

THE OBJECTS OF THE CIO ARE TO ADVANCE HEALTH AND SAVE LIVES IN RELATION TO BLOOD CANCER, IN PARTICULAR BY:- RAISING PUBLIC AWARENESS ABOUT BLOOD CANCER; - FORMULATING AND PROMOTING IMPROVED TREATMENT MECHANISMS AND STRATEGIES THAT MORE EFFECTIVELY ADDRESS THE NEEDS OF PEOPLE AFFECTED BY BLOOD CANCER; AND- PROMOTING COLLABORATION BETWEEN ORGANISATIONS WORKING IN THE FIELD OF BLOOD CANCER, IN ORDER TO MAXIMISE THE VALUE AND BENEFITS OF BLOOD CANCER WORK FOR THE BENEFIT OF THE PUBLIC.NOTHING IN THIS CONSTITUTION SHALL AUTHORISE AN APPLICATION OF THE PROPERTY OF THE CIO FOR THE PURPOSES WHICH ARE NOT CHARITABLE IN ACCORDANCE WITH SECTION 7 OF THE CHARITIES AND TRUSTEE INVESTMENT (SCOTLAND) ACT 2005 AND SECTION 2 OF THE CHARITIES ACT (NORTHERN IRELAND) 2008.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£119k
Latest spending
£120k
Registered
2023
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income for the year was £120,988 against total expenditure of £99,889, resulting in a net surplus of £21,099. Free unrestricted reserves stood at £115,848 at year-end, which is significantly above the trustees' stated reserves requirement of £15,000. The trustees are satisfied that there are no material uncertainties about the charity's ability to continue.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: At least three months of staffing costs and essential operational overheads. Wind-down costs, based on the estimated cost of closing the charity, including any statutory notice and redundancy obligations. Committed strategic projects, but only where funds are held in cash and are readily available for use. (reserves figure: £116k)
“The Blood Cancer Alliance shall maintain reserves sufficient to cover: 1. At least three months of staffing costs and essential operational overheads. 2. Wind-down costs, based on the estimated cost of closing the charity, including any statutory notice and redundancy obligations. 3. Committed strategic projects, but only where funds are held in cash and are readily available for use.” — page 10
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Secondment costs recharged from Myeloma UK (CEO Sophie Castell is BCA Co-chair)
“During the year Myeloma UK employed a member of staff who has been seconded to BCA - the full costs of this employment of £17,104 have been recharged to BCA under a Memorandum of Understanding” — page 15
“During the year 1 trustee was paid a total of £314 in respect of travel” — page 15
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Trustee travel expenses
“During the year Myeloma UK employed a member of staff who has been seconded to BCA - the full costs of this employment of £17,104 have been recharged to BCA under a Memorandum of Understanding” — page 15
“During the year 1 trustee was paid a total of £314 in respect of travel” — page 15
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 30/04/2026

  • Volunteers: 10

Self-declared on the annual return for the financial year ending 30/04/2025

  • Volunteers: 10

Self-declared on the annual return for the financial year ending 30/04/2024

  • Volunteers: 12

Source: this charity’s annual returns on the Charity Commission register.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
30/04/2026£119k£120k
30/04/2025£121k£100k
30/04/2024£176k£81k

Common questions

Is BLOOD CANCER ALLIANCE financially healthy?

Per its FY2025 accounts: The accounts state that total income for the year was £120,988 against total expenditure of £99,889, resulting in a net surplus of £21,099. Free unrestricted reserves stood at £115,848 at year-end, which is significantly above the trustees' stated reserves requirement of £15,000. The trustees are satisfied that there are no material uncertainties about the charity's ability to continue. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with Blood Cancer UK Research.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
BLOOD CANCER ALLIANCE£119k——above—no doubt
Blood Cancer UK Research FY2025£21.1m——unclear—no doubt
FIGHTING ALL CANCERS TOGETHER FY2025£554k—0below—no doubt
A GIFT TO LIFT FY2026£45k—0above—no doubt
BREAST CANCER UK LIMITED FY2025£2.1m—0above17.7%no doubt
ABOVE & BEYOND CANCER FOUNDATION FY2025£82k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.